ReNAgade Therapeutics Appoints Joe Bolen, Ph.D., Chief Science Innovation Officer
Business Wire India ReNAgade Therapeutics, a company unlocking the limitless potential for RNA medicines, today announced that Joe Bolen, Ph.D., an Executive Partner at MPM BioImpact, former Chief Scientific Officer…